Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
CRO
Merck KGaA’s MilliporeSigma acquires Dutch organoid maker
The move builds up MilliporeSigma’s portfolio of cell culture reagents, tools and benchtop instruments for customers, the company said.
Darren Incorvaia
Dec 18, 2024 12:39pm
Roche culls ph. 3 Spark gene therapy in hemophilia
Dec 16, 2024 12:24pm
AbbVie acquires oral peptide biotech Nimble for $200M
Dec 13, 2024 10:38am
2 eye disease biotechs merge, set sights on FDA approval
Dec 12, 2024 11:05am
Pharma and life sci M&A volume dropped 8% in 2024: PwC
Dec 12, 2024 5:00am
Merger for troubled liver disease biotech called off
Dec 11, 2024 12:43pm
